Valens Company Posts Q3 Revenues Of $21.0 Million, Net Loss

The Valens Company (TSX: VLNS) last night released its third quarter financial results. The firm reported net revenues of $21.0 million for the period ended August 31, along with a net loss of $12.8 million and an adjusted EBITDA loss of $6.2 million.

Revenues on a gross basis amounted to $24.6 million, before excise fees netted the company down to $21.0 million. The quarter reported another period of the growth for the company, with the prior quarter seeing $18.8 million in net revenues, while the year ago period had $18.1 million in revenues.

Product sales continue to grow for the company as well, with the firms revenue breakdown seeing $19.5 million in product sales, $0.6 million in toll processing and co-packing, $0.3 million in analytical testing and $0.5 million in other revenue. Product sales grew substantially from $15.1 million in the prior quarter, while toll processing sales fell from $2.6 million as the company refocuses on being a cannabis CPG firm.

Gross profits for the quarter meanwhile amounted to $5.6 million, following cost of sales of $15.2 million. Despite the year over year growth, gross profits were down substantially from the $7.3 million recorded in the year ago period. Furthermore, operating expenses more than doubled from the $10.7 million recorded in Q3 2020 to $19.5 million in the current quarter.

Expenses largely consisted of wages and salaries of $5.4 million (which were nearly equal to gross profits themselves), followed by depreciation and amortization of $3.6 million, advertising commission and selling expenses of $2.3 million, and professional fees of $1.8 million among other expenses. Loss from operations overall amounted to $13.9 million. Following other expenses of $0.8 million, and income tax recoveries of $1.8 million, the company overall posted a loss of $12.8 million for the period.

Looking to the balance sheet, things aren’t much rosier. The company currently has a cash position of $31.0 million, however trade and other receivables are pegged at $41.1 million – nearly two quarters worth of net sales and bringing into question the quality of the firms receivables and the likelihood of collection. As per the MD&A filed, roughly $24.0 million in receivables is over 60 days past due. Total current assets overall are pegged at $138.4 million.

Accounts payable and accrued liabilities are meanwhile sitting at $29.7 million, nearly equal to the firms cash position, while term loans and other debt are pegged at $7.8 million. Lastly, total current liabilities are sitting at $57.2 million overall.

The Valens Company last traded at $2.32 on the TSX.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Valens Company Reports Declining Preliminary Q4 Revenues, Q1 2021 Guidance

The Valens Company (TSX: VLNS) this evening put out preliminary figures for its fourth quarter...

Tuesday, January 19, 2021, 06:13:10 PM

Raymond James Initiates Coverage On The Valens Company, Gives $4 Price Target

This morning Raymond James initiated coverage on The Valens Company (TSX: VLNS) with a C$4...

Monday, June 8, 2020, 04:22:37 PM

Valens Company Sources $40.0 Million Term Loan To Fund Growth

Capital continues to flow into the Canadian cannabis market. The Valens Company (TSX: VLNS) is...

Thursday, December 16, 2021, 07:56:32 AM

Valens Sees Canaccord Cut Price Target After Investor Day

On February 7th, The Valens Company (TSX: VLNS) held its 2022 investor day. The company...

Friday, February 11, 2022, 02:54:00 PM

Valens Reports Q1 Revenue of $31.9 Million, Announces TSX Listing Date

The Valens Company (TSXV: VLNS) reported its first quarter 2020 financials after the bell today,...

Tuesday, April 14, 2020, 05:39:09 PM